X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4472) 4472
Conference Proceeding (170) 170
Publication (143) 143
Book Review (77) 77
Book Chapter (26) 26
Paper (19) 19
Dissertation (12) 12
Government Document (9) 9
Newspaper Article (7) 7
Magazine Article (5) 5
Reference (3) 3
Book / eBook (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
lutetium (1838) 1838
index medicus (935) 935
humans (554) 554
animals (431) 431
radioisotopes (332) 332
materials science (331) 331
yttrium (324) 324
radiology, nuclear medicine & medical imaging (314) 314
materials science, multidisciplinary (310) 310
lutetium - chemistry (302) 302
crystals (298) 298
lutetium compounds (298) 298
mice (294) 294
lutetium isotopes (292) 292
luminescence (275) 275
chemistry, inorganic & nuclear (271) 271
chemistry (262) 262
lutetium - therapeutic use (249) 249
chemistry, physical (246) 246
cerium (245) 245
male (239) 239
rare earth metals (234) 234
rare earths (234) 234
spectroscopy (231) 231
tumors (231) 231
ytterbium (230) 230
chemistry, multidisciplinary (229) 229
physics (229) 229
gadolinium (219) 219
crystal structure (207) 207
cancer (205) 205
female (202) 202
samarium (201) 201
europium (200) 200
lanthanum (199) 199
physics, applied (195) 195
radioisotopes - therapeutic use (195) 195
nuclear science & technology (194) 194
erbium (191) 191
physics, condensed matter (180) 180
analysis (176) 176
spectra (175) 175
radiation therapy (171) 171
nuclear medicine (167) 167
x-ray diffraction (166) 166
thulium (165) 165
terbium (161) 161
dysprosium (159) 159
nuclear physics and radiation physics (157) 157
energy levels (155) 155
ions (155) 155
tissue distribution (153) 153
ligands (150) 150
oncology (150) 150
lutetium oxide (145) 145
complexes (144) 144
optics (144) 144
rare earth compounds (144) 144
metals (143) 143
patients (143) 143
positron emission tomography (143) 143
holmium (142) 142
dosimetry (141) 141
cell line, tumor (138) 138
prostate cancer (136) 136
radiopharmaceuticals - therapeutic use (132) 132
neodymium (131) 131
elements (130) 130
oxides (129) 129
engineering, electrical & electronic (126) 126
electrochemistry (125) 125
isotopes (122) 122
temperature (120) 120
optical properties (119) 119
chemistry, analytical (118) 118
inorganic, organic, physical and analytical chemistry (118) 118
scandium (116) 116
therapy (116) 116
medical imaging (114) 114
radioisotopes - chemistry (114) 114
nuclei (111) 111
synthesis (111) 111
lutetium oxides (110) 110
neuroendocrine tumors (110) 110
prostate (110) 110
radioimmunotherapy (109) 109
detectors (108) 108
lutetium - pharmacokinetics (108) 108
metastases (108) 108
instruments & instrumentation (107) 107
research (106) 106
toxicity (106) 106
peptides (104) 104
phosphors (103) 103
computed tomography (101) 101
decay (101) 101
photoluminescence (100) 100
tomography (100) 100
crystallography (99) 99
lutetium oxyorthosilicate (99) 99
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4466) 4466
German (68) 68
Chinese (19) 19
French (12) 12
Russian (11) 11
Japanese (10) 10
Polish (2) 2
Danish (1) 1
Hungarian (1) 1
Italian (1) 1
Korean (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 1/2015, Volume 42, Issue 1, pp. 5 - 19
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2015, Volume 10, Issue 3, pp. e0120561 - e0120561
Pretargeted radioimmunotherapy (PRIT) is a multi-step method of selectively delivering high doses of radiotherapy to tumor cells while minimizing exposure to... 
Humans | Yttrium Radioisotopes - pharmacokinetics | Immunoconjugates - immunology | Tissue Distribution | Immunoconjugates - therapeutic use | Radioimmunotherapy - methods | Female | Lymphoma - pathology | Lymphoma - radiotherapy | Lutetium - therapeutic use | Yttrium Radioisotopes - therapeutic use | Lutetium - adverse effects | Immunoconjugates - adverse effects | Lutetium - pharmacokinetics | Yttrium Radioisotopes - adverse effects | Antigens, CD20 - immunology | Lymphoma - immunology | Xenograft Model Antitumor Assays | Animals | Cell Transformation, Neoplastic | Mice, Nude | Beta Particles - therapeutic use | Cell Line, Tumor | Mice | Radioimmunotherapy - adverse effects | Bioengineering | Nuclear medicine | Animal models | Dosimeters | Toxicity | Radiation | Radioisotopes | Cancer therapies | Ovarian cancer | Bearing | Beta rays | Lutetium isotopes | Animal tissues | Immunotherapy | Streptavidin | Xenografts | Dosimetry | Isotopes | Drug dosages | Medical research | Tumor cells | Organs | Biotin | Radiation therapy | Lutetium | Lymphoma | Radiation dosage | Yttrium isotopes | Burkitt's lymphoma | Studies | Gamma rays | Chemotherapy | Lymphocytes B | Mantle cell lymphoma | CD20 antigen | Lymphomas | Yttrium | Tumors | B-cell lymphoma | Index Medicus | RADIOLOGY AND NUCLEAR MEDICINE | Radiologi och bildbehandling | Radiology, Nuclear Medicine and Medical Imaging
Journal Article
The Journal of Urology, ISSN 0022-5347, 08/2016, Volume 196, Issue 2, pp. 382 - 391
We report our initial clinical experience with β -emitting Lu-PSMA-I&T ( Lu labeled prostate specific membrane antigen ligand for imaging and therapy) for... 
neoplasm metastasis | lutetium | glutamate carboxypeptidase II, human | castration | prostatic neoplasms
Journal Article
European Urology, ISSN 0302-2838, 2012, Volume 64, Issue 3, pp. 478 - 485
Abstract Background Patients with metastatic clear cell renal cell carcinoma (ccRCC) have a dismal prognosis. Therefore, new and less toxic treatments are... 
Urology | Renal cell carcinoma | cG250 | Lutetium | Radioimmunotherapy | PROTEIN | G250 | HEMATOLOGIC TOXICITY | MYELOTOXICITY | SORAFENIB | CANCER | TRIAL | THERAPY | CLONING | UROLOGY & NEPHROLOGY | DOSIMETRIC ANALYSIS | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Kidney Neoplasms - immunology | Antibodies, Monoclonal - therapeutic use | Male | Carcinoma, Renal Cell - immunology | Tissue Distribution | Radiopharmaceuticals - metabolism | Netherlands | Time Factors | Carbonic Anhydrases - immunology | Immunoconjugates - therapeutic use | Adult | Carcinoma, Renal Cell - enzymology | Female | Whole Body Imaging | Lutetium - therapeutic use | Lutetium - adverse effects | Carbonic Anhydrase IX | Immunoconjugates - adverse effects | Carcinoma, Renal Cell - diagnostic imaging | Antigens, Neoplasm - immunology | Immunoconjugates - metabolism | Treatment Outcome | Tumor Burden | Kidney Neoplasms - radiotherapy | Disease Progression | Carcinoma, Renal Cell - radiotherapy | Maximum Tolerated Dose | Kidney Neoplasms - diagnostic imaging | Carcinoma, Renal Cell - secondary | Kidney Neoplasms - enzymology | Radionuclide Imaging | Kidney Neoplasms - pathology | Aged | Radiopharmaceuticals - adverse effects | Antibodies, Monoclonal - metabolism | Dose-Response Relationship, Radiation | Radioimmunotherapy - adverse effects | Radiopharmaceuticals - therapeutic use | Lutetium - metabolism | Rare earth metals | Medical research | Care and treatment | Monoclonal antibodies | Medicine, Experimental | Carcinoma, Renal cell | Index Medicus
Journal Article
Journal of Luminescence, ISSN 0022-2313, 11/2019, Volume 215
Rounded Lu O :Eu phosphor powder with an average particle size of ~90 nm was synthesized via pyrolyzing the precipitation precursor prepared by a facile... 
Lutetium oxysulfide | Lifetime | Quantum efficiency | Lutetium oxide | Photoluminescence | Red phosphor | Eu3+ dopant
Journal Article
Journal Article
WHO Drug Information, ISSN 1010-9609, 07/2017, Volume 31, Issue 3, pp. 428 - 428
Solution for infusion Class: Radiolabelled peptide targeting subtype 2 somatostatin (sst2) receptors; ATC code: V10XX04 Approval: EMA (orphan designation) Use:... 
Lutetium | Tumors
Journal Article
Journal of Luminescence, ISSN 0022-2313, 01/2017, Volume 181, pp. 277 - 285
The influence of the Mg codoping and annealing in the air on the scintillation and luminescence characteristics of Pr-doped lutetium-aluminum garnet crystals... 
Scintillation | Pr4 | Lutetium–aluminum garnet | Codoping | Luminescence | PULLING-DOWN METHOD | GARNET CRYSTALS | CENTERS | IMPURITIES | RESONANCE | LU3AL5O12 | GROWTH | OPTICS | Lutetium-aluminum garnet | CERAMICS | Annealing | Analysis
Journal Article
Journal of Luminescence, ISSN 0022-2313, 03/2019, Volume 207, pp. 98 - 104
(Lu Mn ) Al (Al Si ) O : Ce solid solution phosphors were synthesized via introducing the isostructural Mn Al (SiO ) (MAS) into Lu Al O : Ce (LuAG). Moreover,... 
Lutetium-Spessartine garnet | Color-tunable | Solid solution phosphor
Journal Article
01/2007
Reference
Optics Letters, ISSN 0146-9592, 10/2014, Volume 39, Issue 20, pp. 5881 - 5884
For the first time, and to the best of our knowledge, we report a continuous-wave (cw) laser operation of Yb:LuPO4 crystal, demonstrated at room temperature in... 
OPTICAL SPECTROSCOPY | OPTICS | DOPED LUTETIUM ORTHOPHOSPHATE
Journal Article
Angewandte Chemie International Edition, ISSN 1433-7851, 08/2014, Volume 53, Issue 35, pp. 9226 - 9230
Journal Article
The Lancet Oncology, ISSN 1470-2045, 06/2018, Volume 19, Issue 6, pp. 825 - 833
Journal Article